NDC 82454-0111

Nilandron

Nilutamide

Nilandron is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Cenexi Hsc. The primary component is Nilutamide.

Product ID82454-0111_d44e4842-09c8-72e9-e053-2a95a90a7c44
NDC82454-0111
Product TypeHuman Prescription Drug
Proprietary NameNilandron
Generic NameNilutamide
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2013-07-15
Marketing CategoryNDA /
Application NumberNDA020169
Labeler NameCENEXI HSC
Substance NameNILUTAMIDE
Active Ingredient Strength150 mg/1
Pharm ClassesAndrogen Receptor Antagonists [MoA],Androgen Receptor Inhibitor [EPC]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 82454-0111-1

3 BLISTER PACK in 1 CARTON (82454-0111-1) > 10 TABLET in 1 BLISTER PACK
Marketing Start Date2013-07-15
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Nilandron" or generic name "Nilutamide"

NDCBrand NameGeneric Name
59212-111NilandronNilutamide
82454-0111NilandronNilutamide
62559-173NilutamideNilutamide
66993-212NilutamideNilutamide
82454-0212NilutamideNilutamide

Trademark Results [Nilandron]

Mark Image

Registration | Serial
Company
Trademark
Application Date
NILANDRON
NILANDRON
74646174 1949186 Live/Registered
CONCORDIA PHARMACEUTICALS INC.
1995-03-13

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.